|Articles|September 1, 1996

September 1996
Volume 2
Issue 8

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

Author(s)William S. Weintraub, MD, Patrick D. Mauldin, PhD, J. David Talley, MD

Key Takeaways

Download PDF: Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

Articles in this issue

almost 30 years ago

Article

The Effectiveness of Postgraduate Education on the Clinical Breast Examination Skills of Primary Care Physicians

almost 30 years ago

Article

Treatment Outcome in an Outpatient Asthma Center: Retrospective Questionnaire Data

almost 30 years ago

Article

Potential Cost-Effectiveness of Acute Stroke Treatment

almost 30 years ago

Article

Effect of a Comprehensive Nurse-Managed Diabetes Program: An HMO Prospective Study

almost 30 years ago

Article

The Economic Organization of Health Resource Allocation: Decision Making in the New Environment

almost 30 years ago

Article

Pharmacoeconomic Evaluation of HMG-CoA Reductase Inhibitors in the Treatment of Hypercholestrolemia

almost 30 years ago

Article

Potential for SSRIs as Monotherapy for Comorbid Psychiatric Disorders

almost 30 years ago

Article

Establishing the Basis for Successful Disease Management Contracting

almost 30 years ago

Article

Accreditation Standards in Managed Care

almost 30 years ago

Article

A Closer Look at Capitation

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

ByAllison Spitery, PharmD, BCACP,Alison Lobkovich, PharmD, BCACP,Emily Thomas, PharmD, BCPS, BCACP

June 4th 2026

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Determinants of Hospital Charges and Costs in Acute Myocardial Infarction: A Report from the Myocardial Infarction Cost Study (MICS) Group

Key Takeaways

Articles in this issue

Related Content

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Real-World Weight Loss With Injectable Semaglutide vs Dulaglutide for Diabetes

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Trending on AJMC

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD

Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention

Social Factors Shape Diabetes, Dementia Risk Across Populations

Bridging Science and Reality in Diabetes Care